BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14687648)

  • 1. Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
    Höchtl T; Horvath Z; Bauer W; Karl D; Saiko P; Elford HL; Fritzer-Szekeres M; Szekeres T
    Life Sci; 2004 Jan; 74(9):1071-80. PubMed ID: 14687648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
    Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Fritzer-Szekeres M; Szekeres T
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1541-4. PubMed ID: 15571294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
    Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
    Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox.
    Grusch M; Fritzer-Szekeres M; Fuhrmann G; Rosenberger G; Luxbacher C; Elford HL; Smid K; Peters GJ; Szekeres T; Krupitza G
    Exp Hematol; 2001 May; 29(5):623-32. PubMed ID: 11376876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Exp Hematol; 2005 Mar; 33(3):329-35. PubMed ID: 15730856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Murias M; Saiko P; Erker T; Handler N; Madlener S; Jaeger W; Grusch M; Fritzer-Szekeres M; Krupitza G; Szekeres T
    Exp Hematol; 2006 Oct; 34(10):1377-84. PubMed ID: 16982330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions.
    Gandhi V; Estey E; Keating MJ; Chucrallah A; Plunkett W
    Blood; 1996 Jan; 87(1):256-64. PubMed ID: 8547650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime.
    Tihan T; Elford HL; Cory JG
    Adv Enzyme Regul; 1991; 31():71-83. PubMed ID: 1877400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.
    Chen P; Aimiuwu J; Xie Z; Wei X; Liu S; Klisovic R; Marcucci G; Chan KK
    AAPS J; 2011 Mar; 13(1):131-40. PubMed ID: 21191677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation.
    Freund A; Rössig C; Lanvers C; Gescher A; Hohenlöchter B; Jürgens H; Boos J
    Ann Oncol; 1999 Mar; 10(3):335-8. PubMed ID: 10355579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical modulation of cytarabine triphosphate by clofarabine.
    Cooper T; Ayres M; Nowak B; Gandhi V
    Cancer Chemother Pharmacol; 2005 Apr; 55(4):361-368. PubMed ID: 15723262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
    Saiko P; Ozsvar-Kozma M; Bernhaus A; Jaschke M; Graser G; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Int J Oncol; 2007 Nov; 31(5):1261-6. PubMed ID: 17912455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
    Fritzer-Szekeres M; Savinc I; Horvath Z; Saiko P; Pemberger M; Graser G; Bernhaus A; Ozsvar-Kozma M; Grusch M; Jaeger W; Szekeres T
    Int J Oncol; 2008 Oct; 33(4):887-92. PubMed ID: 18813804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
    Saiko P; Graser G; Giessrigl B; Lackner A; Grusch M; Krupitza G; Basu A; Sinha BN; Jayaprakash V; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Biochem Pharmacol; 2011 Jan; 81(1):50-9. PubMed ID: 20849828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
    Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ
    Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron binding capacity of didox (3,4 dihydroxybenzohydroxamic acid) and amidox (3,4 dihydroxybenzamidoxime) two inhibitors of the enzyme ribonucleotide reductase.
    Fritzer-Szekeres M; Novotny L; Vachalkova A; Göbl R; Elford HL; Szekeres T
    Adv Exp Med Biol; 1998; 431():599-604. PubMed ID: 9598136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the cellular pharmacology and clinical toxicity of 1-beta-D-arabinofuranosylcytosine.
    Howell SB; Streifel JA; Pfeifle CE
    Med Pediatr Oncol; 1982; 10 Suppl 1():81-91. PubMed ID: 6761570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron binding capacity of didox (3,4-dihydroxybenzohydroxamic acid) and amidox (3,4-dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase.
    Fritzer-Szekeres M; Novotny L; Vachalkova A; Findenig G; Elford HL; Szekeres T
    Life Sci; 1997; 61(22):2231-7. PubMed ID: 9393942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1019-24. PubMed ID: 17065057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.